Thoratec, A Bio Stock With Good Potential And Products Seeking Alpha Historically, heart transplantation is one of the standard methods for approaching end-stage heart disease. But the market has significantly changed to alternative therapies such as the Left Ventricular Assist Device (LVAD) since the FDA approval of ... |
